FDA
approval
· 2022-12-20
FDA Approved: BIMATOPROST — Supplemental Application (Alembic Pharmaceuticals Inc.)
Summary
FDA has approved a supplemental application for BIMATOPROST from Alembic Pharmaceuticals Inc., representing a supplemental approval for the generic ophthalmic p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BIMATOPROST (BIMATOPROST)